Table 3.
Comparison of Urinary Pregnanediol Glucuronide (PDG), Estrone Conjugates (E1c), Follicle Stimulating Hormone (FSH), and Luteinizing Hormone (LH) Among Cancer Survivors, Same Age Controls and Late Reproductive Age Controls
Cancer survivors (n=13) | Same age controls (n=11) | Late reproductive age controls (n=14) | p value Survivors vs. Same age | p value Survivors vs. Late Reproductive age | p value Same age vs. Late Reproductive age | |
---|---|---|---|---|---|---|
PDG Total | 40.0 (31.5-50.9) | 47.1 (36.1-61.5) | 28.2 (22.3-35.5) | 0.37 | 0.04 | <0.01 |
PDG Peak | 3.78 (2.82-5.07) | 4.47 (3.23-6.18) | 2.57 (1.93-3.40) | 0.45 | 0.06 | 0.01 |
PDG Luteal | 24.6 (18.4-33.1) | 28.3 (20.0-39.9) | 19.7 (14.9-26.1) | 0.55 | 0.27 | 0.11 |
PDG Follicular | 12.9 (9.3-17.9) | 16.2 (11.3-23.3) | 6.8 (5.0-9.3) | 0.35 | <0.01 | <0.01 |
E1c Total | 1863 (1482-2344) | 1109 (860-1430) | 1314 (1054-1638) | 0.01 | 0.03 | 0.32 |
E1c Peak | 169 (128-222) | 76 (56-104) | 91 (69.8-118.4) | <0.01 | <0.01 | 0.39 |
E1c Luteal | 848 (610-1178) | 570 (388-838) | 682 (497-936) | 0.13 | 0.34 | 0.47 |
E1c Follicular | 908 (638-1291) | 537 (363-793) | 443 (316-621) | 0.05 | <0.01 | 0.46 |
FSH Total | 839 (642-1096) | 804 (598-1081) | 841 (651-1087) | 0.83 | 0.99 | 0.82 |
FSH Peak | 93 (64-134) | 64 (42-96) | 79 (56-113) | 0.18 | 0.54 | 0.42 |
FSH Follicular | 475 (317-710) | 428 (274-669) | 357 (242-523) | 0.73 | 0.31 | 0.54 |
FSH Luteal | 286 (210-386) | 305 (213-435) | 387 (289-519) | 0.78 | 0.15 | 0.30 |
LH Total | 134 (99-181) | 126 (90-175) | 138 (104-184) | 0.78 | 0.89 | 0.66 |
LH Peak | 26 (17-39) | 19 (12-31) | 23 (15-35) | 0.37 | 0.70 | 0.57 |
LH Follicular | 67 (48-93) | 63 (43-92) | 56 (41-78) | 0.83 | 0.47 | 0.64 |
LH Luteal | 44 (29-67) | 47 (29-77) | 56 (38-83) | 0.83 | 0.40 | 0.59 |
Data presented as geometric mean and 95% CI adjusted for cycle length and days missing